Skip to content

Tokyo / Kanagawa / Chiba / Shizuoka / Ibaraki active OCT applications for ACS (TACTICS registry)

Tokyo / Kanagawa / Chiba / Shizuoka / Ibaraki active OCT applications for ACS (TACTICS registry) - TACTICS registry

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039050
Enrollment
700
Registered
2020-01-06
Start date
2019-11-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome (ACS)

Interventions

None listed

Sponsors

Showa University Division of Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1) Patient who perform primary PCI for acute coronary syndrome (unstable angina and acute myocardial infarction) 2) ACS patients who underwent primary PCI using optical coherence tomography. 3) All patients or proxies receive from physicians the information necessary to give informed consent in writing. 4) Patients aged more than 20 years old.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Patient with limited life expectancy<2 years 2) Patients who can not continue DAPT of aspirin and P2Y12 receptor antagonist. 3) Planned surgery within 3 months. 4) Pregnant or possibility of pregnancy. 5) ACS at a lesion where a stent has already been implanted. 6) Patients unsuitable for OCT-guided PCI. 7) Patient with a history of side effects from aspirin, clopidogrel, or prasugrel. 8) Patients who are difficult to receive 12 months follow-up after primary PCI. 9) Patients judged inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Evaluation of culprit lesion of ACS using OCT 1. Plaque rupture 2. Plaque erosion 3. Calcified nodule 4. Spontaneous coronary artery dissection 5. Others 6. Undecidable

Secondary

MeasureTime frame
1.OCT evaluation 2.Angiographic endpoints 3.clinical events

Countries

Japan

Contacts

Public ContactTakuya Mizukami

TACTICS Study Secretariat Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics

tactics@ofc.showa-u.ac.jp03-3300-5247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026